Identifying new targeted therapy approaches for leukemia

A team of Northwestern Medicine scientists led by Ali Shilatifard, Ph.D., the Robert Francis Furchgott Professor and chair of Biochemistry and Molecular Genetics, has identified the molecular mechanisms of ASXL1 mutations involved in leukemia pathogenesis, according to a study published in Nature Cancer.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *